3.0
14 Sept 2024
Former employee, more than 1 year
Seoul
Recommend
CEO approval
Business outlook
Pros
Work life balance was good when it compared to other global pharma company
Cons
Old system, pipeline was a bit weak
Check out your Company Bowl for anonymous work chats.